Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US department of health and human services secretary's advisory committee on heritable disorders in newborns and children
Open accessAbstract
Purpose The US Secretary of Health and Human Services provides guidance to state newborn screening programs about which conditions should be included in screening (i.e., the "Recommended Uniform Screening Panel"). This guidance is informed by evidence-based recommendations from the Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. This report describes the Advisory Committee's revised decision-making process for considering conditions nominated to the panel.Methods An expert panel meeting was held in April 2012 to revise the decision matrix, which helps to guide the recommendation process. In January 2013, the Advisory Committee voted to adopt the revised decision matrix.Results The revised decision matrix clarifies the approach to rating magnitude and certainty of the net benefit of screening to the population of screened newborns for nominated conditions, and now includes the consideration of the capability of state newborn screening programs for population-wide implementation by evaluating the feasibility and readiness of states to adopt screening for nominated conditions.Conclusion The revised decision matrix will bring increased quality, transparency, and consistency to the process of modifying the recommended uniform screening panel and will now allow formal evaluation of the challenges that state newborn screening programs face in adopting screening for new conditions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the United States, nomination of a condition to the Recommended Uniform Newborn Screening Panel requires a high certainty that screening would lead to significant net benefit, high-to-moderate feasibility, and ability to implement within 3 years.
“In the United States, nomination of a condition to the Recommended Uniform Newborn Screening Panel requires a high certainty that screening for the targeted condition would lead to a significant net benefit, that screening has high-to-moderate feasibility and that most state screening programs would be able to implement screening within 3 years.95”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [95]
The citation lists haven’t been fetched yet
References 7 · Cited by 142
- Authors
- Kemper, A. R., Green, N. S., Calonge, N., Lam, W. K. K., Comeau, A. M., Goldenberg, A. J., Ojodu, J., Prosser, L. A., Tanksley, S., & Bocchini Jr, J. A.
- Affiliations
- Duke University (US)
- Columbia University Irving Medical Center (US)
- Colorado Trust (US)
- University of Massachusetts Chan Medical School (US)
- Case Western Reserve University (US)
- Association of Public Health Laboratories (US)
- University of Michigan (US)
- Texas Department of State Health Services (US)
- Corresponding author
- Kemper, Alex R.
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 16
- Issue
- 2
- Pages
- 183-187
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2068962868
- Cited by
- 142
- References
- 7
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 12 · 2023: 14 · 2022: 18 · 2021: 3 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 11 · 2016: 11 · 2015: 19 · 2014: 9 · 2013: 1 · 2012: 1
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- U.S. Public Health Service (U32-MC00148)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Keywords
- newborn screening, decision matrix, genetic disorders, feasibility assessment
- MeSH terms
- Child, Child, Preschool, Decision Making, Humans, Infant, Infant, Newborn, United States, United States Dept. of Health and Human Services, Neonatal Screening, Evidence-Based Medicine, Advisory Committees
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review